Expression of MHC class I determinants on erythrocytes of SLE patients.
Strong expression of MHC Class I determinants had been observed on the erythrocytes of three genetically C4 deficient patients who all had SLE. In a study of 35 other SLE patients who were not C4 deficient, 30 showed a marked increase in the expression of MHC Class I on their erythrocytes. There was a correlation between the expression of erythrocyte Class I and disease activity. The polymorphic HLA determinants were detected by haemagglutination with human cytotoxic antisera from untransfused pregnant women. A shared monomorphic epitope of HLA-A, -B and -C, and beta 2-microglobulin were detected by haemagglutination with monoclonal antibodies. A monoclonal antibody for a monomorphic epitope on MHC Class II alpha and beta chains did not react. Erythrocytes from a group of RA patients and a group of normal controls had moderate and low expression respectively. We suggest that MHC Class I may be induced on erythrocytes maturing in a milieu containing mediators derived from activated cells of the immune system. Aberrant tissue expression of MHC antigens may be more widespread than has been previously recognized in diseases mediated by immune mechanisms.
Giles
C M
CM
Department of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Walport
M J
MJ
David
J
J
Darke
C
C
D001172:Arthritis, Rheumatoid / Q000276:immunology; D003181:Complement C4 / Q000172:deficiency; D003298:Coombs Test; D004912:Erythrocytes / Q000276:immunology*; D006680:HLA Antigens / Q000032:analysis*; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000235:genetics / Q000276:immunology*; D001613:beta 2-Microglobulin / Q000032:analysis
D003181:Complement C4; D006680:HLA Antigens; D007106:Immune Sera; D001613:beta 2-Microglobulin